18.12.2012
- Amgen pleaded guilty in a federal court in New York on Tuesday to misbranding its Aranesp anemia drug and agreed to pay $762 million in a civil settlement and criminal fines. The...
10.12.2012
- U.S. biotechnology group Amgen has agreed to buy unlisted Decode Genetics, a pioneer in gene research, for $415 million to boost its drive to develop better targeted drugs. Founded...
04.12.2012
- Drug companies are becoming more efficient in hunting for new treatments, though this has yet to be reflected in improved investment returns, according to a report on Tuesday. Low...
24.10.2012
- Amgen on Tuesday reported higher-than-expected third-quarter profit in its first full quarter under Chief Executive Robert Bradway and it raised its full-year earnings and revenue...
25.09.2012
- Pharmaceuticals - Of the many challenges inherent with biosimilar development, the inability to predict market expectations may top the list for decision makers. While uncertainty...
30.08.2012
- U.S. drug regulators gave the nod to a Teva Pharmaceutical Industries drug that boosts the production of infection-fighting white blood cells in certain cancer patients receiving...
27.07.2012
- Amgen on Thursday reported far higher-than-expected second-quarter profit and revenue on strong demand for many of its drugs, and the world's largest biotechnology company raised...
30.06.2012
- Simon Lowth may only be the interim chief executive of AstraZeneca but he is ready to sign off on bold deals. The decision to pair up with Bristol-Myers Squibb to buy diabetes...
